Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 120

Results For "RSE"

1333 News Found

American Diabetes Association acknowledges Breath Well-being diabetes reversal programme
News | October 13, 2021

American Diabetes Association acknowledges Breath Well-being diabetes reversal programme

BDMP is a personalised program delivered through the Breathe app to assist people with Type 2 Diabetics to achieve healthy outcomes


Skanray to raise Rs 400 crore to fund its inorganic growth
News | October 12, 2021

Skanray to raise Rs 400 crore to fund its inorganic growth

Since its inception, the company has either acquired or taken a majority stake in five companies


Tarsons earmarks funds from IPO to double capacity at its Panchla facility
News | October 12, 2021

Tarsons earmarks funds from IPO to double capacity at its Panchla facility

An amount of Rs. 70.9 crore has been earmarked for funding capital expenditure for the proposed expansion


Covaxin for kids gets nod, final approval awaited
Drug Approval | October 12, 2021

Covaxin for kids gets nod, final approval awaited

The two doses of Covaxin are likely to be administered to children with a gap of 28 days


IDFC FIRST Bank & Banyan Academy launch Centre for Trauma Studies & Innovation
Healthcare | October 11, 2021

IDFC FIRST Bank & Banyan Academy launch Centre for Trauma Studies & Innovation

Through this initiative, the Centre for Trauma will create curriculums and facilitate trauma-related courses for healthcare professionals at both urban and grassroot levels


Glenmark launches Tavulus for COPD treatment in Spain
Drug Approval | October 11, 2021

Glenmark launches Tavulus for COPD treatment in Spain

It is one of the first companies to launch a bioequivalent version of the dry powder inhaler and it's part of the company’s strategic exclusive in-licensing arrangement to market Tiotropium DPI in Western Europe and the UK


Merck and Ridgeback seek EUA from U.S. FDA for molnupiravir
News | October 11, 2021

Merck and Ridgeback seek EUA from U.S. FDA for molnupiravir

If authorized, molnupiravir could be the first oral antiviral medicine for the treatment of Covid-19


Sai Life Sciences presents its midterm report
News | October 11, 2021

Sai Life Sciences presents its midterm report

The company has enabled a transformation across three core areas with an investment target of US $ 150 million


Gland Pharma receives tentative nod for Sugammadex injection
Drug Approval | October 09, 2021

Gland Pharma receives tentative nod for Sugammadex injection

The injection is used to reverse the effects of the muscle relaxants given to patients during surgery


Thermo Fisher Scientific introduces On the Go mobile app in India
Digitisation | October 07, 2021

Thermo Fisher Scientific introduces On the Go mobile app in India

The applications navigate through more than 100 workflows across biotech, pharma, healthcare, food, forensics, industrial and applied sciences industries